Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
Modulation of dopamine D-1 receptors via histamine H-3 receptors is a novel therapeutic target for Huntington's disease
QMRO Home
William Harvey Research Institute
Centre for Endocrinology
Modulation of dopamine D-1 receptors via histamine H-3 receptors is a novel therapeutic target for Huntington's disease
QMRO Home
William Harvey Research Institute
Centre for Endocrinology
Modulation of dopamine D-1 receptors via histamine H-3 receptors is a novel therapeutic target for Huntington's disease
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
Modulation of dopamine D-1 receptors via histamine H-3 receptors is a novel therapeutic target for Huntington's disease
View/
Open
Published version (4.790Mb)
Volume
9
DOI
10.7554/eLife.51093
Journal
ELIFE
ISSN
2050-084X
Metadata
Show full item record
Authors
Moreno-Delgado, D; Puigdellivol, M; Moreno, E; Rodriguez-Ruiz, M; Botta, J; Gasperini, P; Chiarlone, A; Howell, LA; Scarselli, M; Casado, V
URI
https://qmro.qmul.ac.uk/xmlui/handle/123456789/68432
Collections
Centre for Endocrinology
[560]
Licence information
Creative Commons Attribution License
Copyright statements
(c) Moreno-Delgado et al.
Except where otherwise noted, this item's license is described as Creative Commons Attribution License